// App-Quantinova.ai

538P : Relationship between pretreatment levels of circulating DNA, circulating tumor cells, CEA, CA19.9 and tumor burden on CT scan in patients treated for a metastatic colorectal cancer

Researchers

Presenter

  • M.Hassine

Principal Investigators

  • C.Savoye-Collet

  • D.Sefrioui

  • L.Beaussire

  • A.Gillibert

  • A.Gangloff

  • N.Sarafan-Vasseur

  • P.Michel

  • F.Di Fiore

Medical Centers

  • Pneumology, CHU Hôpitaux de Rouen-Charles Nicolle, Rouen, France

  • Rheumatology, University Hospital, Lille, France,

  • Institute for Biomedical Research and Innovation, University Hospital of Rouen, Rouen, France

  • Biostatistics, University Hospital, Lille, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • Carcinoembryonic antigen

  • Circulating tumor cells

  • Circulating DNA

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved